# CONMED Corp: filings

CNMD · NYSE · CIK 816956 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnmd.md) · [Financials](/companies/cnmd/financials.md) · [Filings](/companies/cnmd/filings.md) · [Insiders](/companies/cnmd/insiders.md)

## Reports and events: 308 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 964, 8-K 202, SC 13G/A 90, 10-Q 53, 3 37, 5 29, 144 28, 4/A 28, 10-K 18, 11-K 18, UPLOAD 18, DEF 14A 17, DEFA14A 17, SC 13G 17, S-8 POS 16, SD 13, SC 13D/A 12, DFAN14A 10, S-8 8, CORRESP 7, ARS 4, SC 13D 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, SC TO-C 3, SC TO-T/A 3, 3/A 2, 8-K/A 2, DEFC14A 2, PRE 14A 2, PREC14A 2, PRRN14A 2, 10-K/A 1, 25 1, 25-NSE 1, 8-A12B 1, CERT 1, PRER14A 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-29 | 16:13 ET | [10-Q](/filings/0000816956-26-000102.md) | Quarterly report, period 2026-06-30 | 0000816956-26-000102 |
| 2026-07-29 | 16:10 ET | [8-K](/filings/0000816956-26-000101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-26-000101 |
| 2026-06-17 | 16:49 ET | [8-K](/filings/0002077096-26-000203.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002077096-26-000203 |
| 2026-06-04 | 07:30 ET | [8-K](/filings/0001174947-26-000639.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001174947-26-000639 |
| 2026-06-01 | 08:31 ET | [8-K](/filings/0002077096-26-000190.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0002077096-26-000190 |
| 2026-05-20 | 08:30 ET | [8-K](/filings/0000816956-26-000057.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000816956-26-000057 |
| 2026-04-30 | 09:52 ET | [10-Q](/filings/0000816956-26-000053.md) | Quarterly report, period 2026-03-31 | 0000816956-26-000053 |
| 2026-04-29 | 16:18 ET | [8-K](/filings/0000816956-26-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-26-000051 |
| 2026-04-07 | 08:23 ET | [DEF 14A](/filings/0000816956-26-000047.md) | Proxy statement, period 2026-05-18 | 0000816956-26-000047 |
| 2026-03-13 | 16:01 ET | [8-K](/filings/0001213900-26-027658.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-027658 |
| 2026-02-17 | 11:01 ET | [10-K](/filings/0000816956-26-000009.md) | Annual report, period 2025-12-31 | 0000816956-26-000009 |
| 2026-01-28 | 16:13 ET | [8-K](/filings/0000816956-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-26-000006 |
| 2026-01-12 | 09:00 ET | [8-K](/filings/0001174947-26-000024.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001174947-26-000024 |
| 2026-01-08 | 17:00 ET | [8-K](/filings/0001174947-26-000017.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001174947-26-000017 |
| 2025-12-05 | 08:09 ET | [8-K](/filings/0001213900-25-118476.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-118476 |
| 2025-11-06 | 12:39 ET | [10-Q](/filings/0000816956-25-000056.md) | Quarterly report, period 2025-09-30 | 0000816956-25-000056 |
| 2025-11-05 | 16:15 ET | [8-K](/filings/0000816956-25-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-25-000054 |
| 2025-09-09 | 16:11 ET | [8-K](/filings/0001174947-25-001185.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001174947-25-001185 |
| 2025-08-08 | 14:17 ET | [8-K](/filings/0000816956-25-000031.md) | 8.01 Other events | 0000816956-25-000031 |
| 2025-07-31 | 09:25 ET | [10-Q](/filings/0000816956-25-000028.md) | Quarterly report, period 2025-06-30 | 0000816956-25-000028 |
| 2025-07-30 | 16:17 ET | [8-K](/filings/0000816956-25-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-25-000026 |
| 2025-07-07 | 17:05 ET | [8-K](/filings/0001174947-25-000987.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001174947-25-000987 |
| 2025-06-16 | 16:31 ET | [8-K](/filings/0001174947-25-000941.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001174947-25-000941 |
| 2025-05-21 | 16:03 ET | [8-K](/filings/0001174947-25-000828.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001174947-25-000828 |
| 2025-05-01 | 11:07 ET | [10-Q](/filings/0000816956-25-000011.md) | Quarterly report, period 2025-03-31 | 0000816956-25-000011 |
| 2025-04-30 | 16:13 ET | [8-K](/filings/0001174947-25-000654.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-25-000654 |
| 2025-04-08 | 16:05 ET | [DEF 14A](/filings/0001193125-25-075693.md) | Proxy statement, period 2025-05-20 | 0001193125-25-075693 |
| 2025-04-01 | 16:06 ET | [8-K](/filings/0001174947-25-000453.md) | 5.02 Departure or appointment of officers or directors | 0001174947-25-000453 |
| 2025-02-25 | 17:05 ET | [8-K](/filings/0001174947-25-000234.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001174947-25-000234 |
| 2025-02-18 | 10:15 ET | [10-K](/filings/0000816956-25-000004.md) | Annual report, period 2024-12-31 | 0000816956-25-000004 |
| 2025-02-05 | 16:15 ET | [8-K](/filings/0001174947-25-000129.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-25-000129 |
| 2025-01-13 | 09:00 ET | [8-K](/filings/0001193125-25-005046.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005046 |
| 2024-12-10 | 09:03 ET | [8-K](/filings/0001174947-24-001328.md) | 8.01 Other events | 0001174947-24-001328 |
| 2024-10-31 | 08:52 ET | [10-Q](/filings/0000816956-24-000018.md) | Quarterly report, period 2024-09-30 | 0000816956-24-000018 |
| 2024-10-30 | 16:09 ET | [8-K](/filings/0001193125-24-247545.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-247545 |
| 2024-10-04 | 08:08 ET | [8-K](/filings/0001193125-24-232621.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-232621 |
| 2024-09-30 | 11:45 ET | [8-K](/filings/0001193125-24-228650.md) | 7.01 Regulation FD disclosure | 0001193125-24-228650 |
| 2024-09-20 | 17:07 ET | [8-K](/filings/0001193125-24-222986.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-222986 |
| 2024-08-14 | 16:37 ET | [8-K](/filings/0001193125-24-200674.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-200674 |
| 2024-08-09 | 16:11 ET | [8-K](/filings/0001174947-24-000987.md) | 8.01 Other events | 0001174947-24-000987 |
| 2024-08-01 | 10:40 ET | [10-Q](/filings/0000816956-24-000015.md) | Quarterly report, period 2024-06-30 | 0000816956-24-000015 |
| 2024-07-31 | 16:19 ET | [8-K](/filings/0001174947-24-000936.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-24-000936 |
| 2024-05-28 | 16:15 ET | [8-K](/filings/0001174947-24-000761.md) | 5.02 Departure or appointment of officers or directors | 0001174947-24-000761 |
| 2024-05-22 | 17:12 ET | [8-K](/filings/0001104659-24-064334.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-24-064334 |
| 2024-04-25 | 09:52 ET | [10-Q](/filings/0000816956-24-000006.md) | Quarterly report, period 2024-03-31 | 0000816956-24-000006 |
| 2024-04-24 | 16:15 ET | [8-K](/filings/0001193125-24-110117.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-110117 |
| 2024-04-24 | 16:06 ET | [8-K](/filings/0001174947-24-000582.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-24-000582 |
| 2024-04-08 | 06:46 ET | [DEF 14A](/filings/0001193125-24-089093.md) | Proxy statement, period 2024-05-22 | 0001193125-24-089093 |
| 2024-02-28 | 08:57 ET | [10-K](/filings/0000816956-24-000003.md) | Annual report, period 2023-12-31 | 0000816956-24-000003 |
| 2024-02-27 | 16:37 ET | [8-K](/filings/0001174947-24-000261.md) | 8.01 Other events | 0001174947-24-000261 |

Page 1 of 7. [Older](/companies/cnmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.